INDIAN BENCHMARKS open in negative note
owing to muted global cues. Bajaj Finance targeting to raise Rs25bn through a
fixed deposit scheme in the next three years to strengthen its nascent wealth
management business.
FURTHER, Shares of
Ranbaxy Laboratories hit 16% lower circuit at Rs348 after FDA prohibited
Ranbaxy’s Toansa, India facility from producing and distributing drugs
for the U.S. market. Cairn
India fell after the company's consolidated profit after tax fell 14% to Rs
2884 crore on 17% growth in revenue to Rs 5000 crore in Q3 December 2013 over
Q3 December 2012.
Trend in FII flows: The FIIs
were net buyers of Rs.433cr in the cash segment on Thursday while the
domestic institutional investors (DIIs) were net sellers
of Rs. 393cr, as per the provisional figures released by the NSE.
For More Services ..
visit on :- www.capitalstars.com/services.php
OR,
Call us :- 09200099927
my facebook page is below
No comments :
Post a Comment
Your Comment Will Be Submitted!!!!